HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis
Abstract
Authors
GN Okoli N Askin R Rabbani